Doctor of Osteopathy Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

John Yingling

Orthopaedic Surgery Oklahoma City, OK Doctor of Osteopathy

NPI 1164800058 CMS profile 8790116

825 Ne 10Th St Ste 1C, Oklahoma City, OK 73104

Open in the dashboard

General payments

$36,097

204 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, John Yingling of Oklahoma City, OK is reported in the CMS Open Payments database as having received $36,097 across 204 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $12,768 26
2024 General $7,764 55
2023 General $8,937 46
2022 General $3,220 53
2021 General $3,393 23
2020 General $15 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Yingling
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to John Yingling were reported at $12,768. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year John Yingling Orthopaedic Surgery median Middle half National median
2019 $0 $644 $140–$2,844 $163
2020 $15 $312 $75–$1,860 $114
2021 $3,393 $520 $117–$2,495 $132
2022 $3,220 $598 $128–$2,731 $149
2023 $8,937 $461 $128–$2,264 $160
2024 $7,764 $497 $134–$2,475 $164
2025 $12,768 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. CurvaFix, Inc. $22,923 12 payments
  2. Stryker Corporation $5,608 98 payments
  3. Arthrex, Inc. $2,916 12 payments
  4. Smith+Nephew, Inc. $1,748 45 payments
  5. US Implant Solutions, LLC $1,591 8 payments
  6. Acera Surgical, Inc. $455 12 payments
  7. Pylant Medical $342 6 payments
  8. Onkos Surgical, Inc. $150 1 payment
  9. DePuy Synthes Sales Inc. $139 3 payments
  10. Acumed LLC $84 2 payments
  11. Other $142 5 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Honoraria $19,500 6 payments
  2. Food and Beverage $8,795 184 payments
  3. Travel and Lodging $3,563 11 payments
  4. Education $2,400 2 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,839 1 payment
Products named General payments · program years 2020–2025
  1. CurvaFix IM Implant $22,923 12 payments
  2. PRO $1,263 7 payments
  3. T2 $1,132 21 payments
  4. T2 ALPHA $996 19 payments
  5. AXSOS $972 16 payments
  6. HOFFMANN $714 16 payments
  7. EVOS $679 18 payments
  8. VARIAX $648 8 payments
  9. GAMMA $612 12 payments
  10. TRIGEN INTERTAN $591 8 payments
  11. Other $3,163 76 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

37

Median for Orthopedic Surgery: 203

Drug cost

$425

Median for Orthopedic Surgery: $1,433

Branded share of claims

100%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 19 $283
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 18 $141

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 103 billing codes

Paid by Medicare

$107,971

Medicare's payments for the services billed

Medicare patients

112

Average age 73

Services billed

221

73 women, 39 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 65%
Depression 52%
Chronic kidney disease 43%
Diabetes 40%
Ischemic heart disease 40%
Osteoporosis 37%
Heart failure 35%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

204 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Oklahoma

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record